We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPolar Capital Regulatory News (POLR)

Share Price Information for Polar Capital (POLR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 528.00
Bid: 527.00
Ask: 529.00
Change: -4.00 (-0.75%)
Spread: 2.00 (0.38%)
Open: 525.00
High: 529.00
Low: 523.00
Prev. Close: 532.00
POLR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AUM Update

14 Apr 2016 07:00

RNS Number : 1355V
Polar Capital Holdings PLC
14 April 2016
 

14 April 2016

Polar Capital Holdings plc

AUM Update

 

Polar Capital Holdings plc ("Polar Capital" or the "Group"), the specialist asset management group, today provides its regular quarterly update of its unaudited statement of its Assets under Management ("AUM").

 

Group AUM (unaudited)

 

Polar Capital reports that as at 31 March 2016 its AUM were $10.4bn (£7.3bn) compared to $12.3bn (£8.3bn) at the end of March 2015.

 

AUM movement in

Twelve months to

31 March 2016

USD

GBP

Long only

Funds

Alternative funds

Total

Long only

funds

Alternative funds

Total

AUM at

31 March 2015

$11,185m

$1,071m

$12,256m

£7,548m

£723m

£8,271m

Net subscriptions

/ (redemptions)

$(957)m

$21m

$(936)m

£(634)m

£14m

£(620)m

Market movement

and performance

$(850)m

$(37)m

$(887)m

£(383)m

£(3)m

£(386)m

Total AUM at

31 March 2016

$9,378m

$1,055m

$10,433m

£6,531m

£734m

£7,265m

 

Comment

 

As at the end of March our AUM were £7.3bn, down almost 10% from the level reported at the end of December 2015 and down 12% from the level at the same time last year. Our financial year finished on a disappointing note with a pickup in outflows from our Japan fund following another period of difficult performance.

Prior to the introduction of Abenomics in October 2012 our Japan UCITS had outperformed its benchmark by 57% since its launch in 2001. However, since Abenomics the process that the team deploys has not been able to deliver comparable returns and indeed has underperformed the market by a considerable margin over this period.

This has been disappointing for clients and for the team. The team remain committed to their process and believe at some point the approach will once again deliver significant outperformance for those clients who have an investment horizon beyond the current extreme volatility in Japan.

Although over the last twelve months the AUM across our other funds decreased the reduction has been a product of market moves as net inflows of $240m were received into the Group's non Japan funds over the period.

The breadth of product we are seeing both inflows and interest in from clients gives us confidence that once our Japanese business stabilises, we can once again start growing our AUM and profits. Near term though the outlook for global stock markets remains highly uncertain and this will continue to have an impact on our business over the shorter term.

Polar Capital's focus on investment expertise and our structure, as well as our own recruitment efforts continue to mean we are able to attract additional teams either with assets or whose track-record is such that assets will likely follow quickly. As has recently been reported in the media, we are looking forward to welcoming the highly rated UK Value team of George Godber and Georgina Hamilton to our Group in due course. 

As a consequence of the pipeline of further recruitment activity we now have in place we are revising, for the first time in fifteen years, our targeted number of teams from 10 to 12 to a new range of 12 to 15. We have spent a number of years building up our operational support structure within Polar Capital and this now means we have the necessary resource to offer additional teams the highest level of support, whilst maintaining the culture of our Group.

Our long term performance record remains strong despite the near term challenges posed by recent global market volatility with 14 funds out of our 18 UCITS funds ahead of their benchmark since launch, net of all costs.

Even though our AUM at the end of our financial year are less than had been anticipated, our financial position is such that the Group wishes to confirm to shareholders that it would expect to maintain the dividend at last year's level.

 

For further information please contact:

 

Polar Capital

Tim Woolley (CEO)John Mansell (COO)

+44 (0)20 7227 2700

Canaccord Genuity - Nomad and Joint Broker

Simon Bridges (QE)

Kit Stephenson

+44 (0)20 7523 8000

 

Peel Hunt - Joint Broker

Guy Wiehahn

+44 (0)20 7418 8893

Camarco

Ed Gascoigne-Pees

 

+44 (0)20 3757 4984

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEAXLDFENKEFF
Date   Source Headline
17th Apr 20243:55 pmRNSDirector/PDMR Shareholding
12th Apr 20245:43 pmRNSHolding(s) in Company
11th Apr 20247:00 amRNSAuM Update
9th Apr 20244:01 pmRNSChange of Company Secretary
15th Mar 20243:02 pmRNSForm 8.3 - Renalytix PLC
15th Mar 202410:23 amRNSForm 8.3 - Renalytix PLC - Replacement
13th Mar 20246:14 pmRNSForm 8.3 - RENALYTIX PLC
7th Mar 20244:30 pmRNSHolding(s) in Company
6th Mar 20245:47 pmRNSForm 8.3 - DIRECT LINE INSURANCE GROUP PLC
6th Mar 20245:37 pmRNSForm 8.3 - RENALYTIX PLC
27th Feb 20242:19 pmRNSForm 8.3 - Wincanton PLC
7th Feb 20242:09 pmRNSDirector/PDMR Shareholding
1st Feb 20247:00 amRNSBlock listing Interim Review
25th Jan 20244:53 pmRNSForm 8.3 -Wincanton PLC
11th Jan 20247:00 amRNSAuM Update
10th Jan 20242:54 pmRNSHolding(s) in Company
10th Jan 20242:51 pmRNSHolding(s) in Company
20th Nov 20237:00 amRNSPolar Capital Holdings Unaudited interim results
9th Nov 20237:00 amRNSInvestor Presentation covering Interim Results
26th Oct 20237:00 amRNSNotice of Interim Results
12th Oct 20237:00 amRNSAuM Update
28th Sep 20235:36 pmRNSResult of AGM
18th Aug 20234:45 pmRNSDirector/PDMR Shareholding
1st Aug 202312:05 pmRNSBlock listing Interim Review
19th Jul 20234:34 pmRNSDirector/PDMR Shareholding
18th Jul 20234:30 pmRNSDirector/PDMR Shareholding
13th Jul 202311:01 amRNSDirector/PDMR Shareholding - Replacement
13th Jul 202310:48 amRNSDirector/PDMR Shareholding
13th Jul 202310:31 amRNSDirector/PDMR Shareholding
13th Jul 20237:00 amRNSAuM Update
26th Jun 20233:34 pmRNSInvestor Presentation covering Full Year Results
26th Jun 20237:00 amRNSGroup Audited Results for year ended 31 March 2023
1st Jun 20237:00 amRNSTotal Voting Rights
25th May 202312:26 pmRNSIssue of Equity
10th May 20233:10 pmRNSDirector/PDMR Shareholding
21st Apr 20232:36 pmRNSHolding(s) in Company
14th Apr 20234:01 pmRNSDirector/PDMR Shareholding
13th Apr 20237:00 amRNSAuM Update
31st Mar 202312:23 pmRNSDirector/PDMR Shareholding
10th Mar 20233:17 pmRNSDirector/PDMR Shareholding
24th Feb 20235:18 pmRNSForm 8.3 - REDX Pharma PLC
16th Feb 20235:06 pmRNSDirector/PDMR Shareholding
7th Feb 202311:09 amRNSHolding(s) in Company
1st Feb 20237:00 amRNSBlock listing Interim Review
12th Jan 20237:00 amRNSAuM Update
30th Dec 20227:00 amRNSDirectorate Change
21st Nov 20227:00 amRNSUnaudited interim results
15th Nov 20227:00 amRNSInvestor Presentation covering Interim Results
24th Oct 20227:00 amRNSNotice of Results
19th Oct 20222:52 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.